{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:18:11Z","timestamp":1783160291165,"version":"3.54.6"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["25-25-00358"],"award-info":[{"award-number":["25-25-00358"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clinbiochem.2025.111016","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:11:29Z","timestamp":1758381089000},"page":"111016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Modified LDL variants in atherosclerosis: molecular pathways, diagnostic potential, and therapeutic perspectives"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0547-6310","authenticated-orcid":false,"given":"Siarhei A.","family":"Dabravolski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Golovyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga N.","family":"Maltseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra S.","family":"Utkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alikhan Z.","family":"Asoyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N.","family":"Orekhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2025.111016_b0005","unstructured":"WHO CVDs Fact sheets Cardiovascular Diseases (CVDs). Available online: https:\/\/www.who.int\/health-topics\/cardiovascular-diseases#tab=tab_1 (accessed on 11 December 2024)."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/pin.13202","article-title":"Atherosclerosis: known and unknown","volume":"72","author":"Fan","year":"2022","journal-title":"Pathol. Int."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0015","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacl.2019.05.004","article-title":"Low-density lipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: the international cholesterol management practice study","volume":"13","author":"Blom","year":"2019","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0020","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/eurheartj\/ehx373","article-title":"METASTROKE collaboration of the ISGC differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke","volume":"39","author":"Hopewell","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0025","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007091","article-title":"Relative effects of LDL-C on ischemic stroke and coronary disease: a Mendelian randomization study","volume":"92","author":"Valdes-Marquez","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.athplu.2022.03.006","article-title":"Secular trends in serum lipid profiles in young adults in Norway, 2001-19","volume":"48","author":"Arnesen","year":"2022","journal-title":"Atherosclerosis Plus"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12944-022-01747-2","article-title":"Long-term prognostic value of LDL-C, HDL-C, Lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002\u20132012)","volume":"21","author":"Georgoulis","year":"2022","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ije\/dyz099","article-title":"National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries","volume":"49","author":"Taddei","year":"2020","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0045","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.arcmed.2017.11.001","article-title":"Effect of native and minimally modified low-density lipoprotein on the activation of monocyte subsets","volume":"48","author":"Blanco-Favela","year":"2017","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0050","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3390\/biomedicines9070782","article-title":"The importance of lipoprotein lipase regulation in atherosclerosis","volume":"9","author":"Kumari","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0055","first-page":"3","article-title":"Phospholipase A2 is an inflammatory predictor in cardiovascular diseases: is there any spacious room to prove the causation?","volume":"16","author":"Santoso","year":"2020","journal-title":"CCR"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0060","doi-asserted-by":"crossref","first-page":"681","DOI":"10.33594\/000000048","article-title":"The scavenger receptor CD68 regulates platelet mediated oxidized low-density lipoprotein (oxLDL) deposition in atherosclerotic vessels at an early stage of atherosclerosis in LDLR-\/-\/ApoBec-\/- mice","volume":"52","author":"Zeibig","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12951-018-0352-3","article-title":"Comparative Investigation on the Sizes and Scavenger Receptor Binding of Human Native and Modified Lipoprotein Particles with Atomic Force Microscopy","volume":"16","author":"Gan","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/5245308","article-title":"Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis","volume":"2020","author":"Khatana","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0075","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.2174\/0109298673294245240102105814","article-title":"Non-oxidative vs oxidative forms of modified low-density lipoprotein: what is more important in atherogenesis?","volume":"31","author":"Orekhov","year":"2024","journal-title":"CMC"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.abb.2015.03.008","article-title":"Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): implications for foam cell formation in atherosclerosis","volume":"573","author":"Ismael","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100444","article-title":"Myeloperoxidase enzymatic activity is key to understanding its potential as a biomarker in vulnerable atherosclerosis","volume":"2","author":"Nadel","year":"2023","journal-title":"JACC Adv."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0090","doi-asserted-by":"crossref","DOI":"10.2174\/0109298673283640231208103306","article-title":"We must abandon the myth: oxidized low-density lipoprotein is not a lipoprotein that plays a key role in atherogenesis","volume":"31","author":"Orekhov","year":"2024","journal-title":"CMC"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1094188","article-title":"Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis","volume":"10","author":"Poznyak","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0100","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00726-010-0783-0","article-title":"Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome","volume":"42","author":"Rabbani","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0105","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2337\/db11-0085","article-title":"Glycation of LDL by methylglyoxal increases arterial atherogenicity","volume":"60","author":"Rabbani","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0110","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2741\/4640","article-title":"Modified low-density lipoproteins as biomarkers in diabetes and metabolic syndrome","volume":"23","author":"Sanchez-Quesada","year":"2018","journal-title":"Front Biosci"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0115","doi-asserted-by":"crossref","first-page":"496","DOI":"10.18433\/jpps29872","article-title":"The use of high sensitivity C-reactive protein in cardiovascular disease detection","volume":"21","author":"Castro","year":"2018","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tcm.2021.02.001","article-title":"Role of inflammatory cytokines in genesis and treatment of atherosclerosis","volume":"32","author":"Biros","year":"2022","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0125","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.3390\/ijms22137061","article-title":"Anti-inflammatory therapy for atherosclerosis: focusing on cytokines","volume":"22","author":"Poznyak","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0130","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41577-024-01010-y","article-title":"Breaking tolerance: the autoimmune aspect of atherosclerosis","volume":"24","author":"Khan","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0135","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in atherothrombosis","volume":"72","author":"Libby","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0140","article-title":"Foam cells: the origin of formation and target for plant-derived bioactive compounds","volume":"31","author":"Dabravolski","year":"2024","journal-title":"CMC"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0145","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.3390\/antiox11071408","article-title":"Role of oxidative stress in the pathogenesis of atherothrombotic diseases","volume":"11","author":"Petrucci","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0150","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","article-title":"Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies","volume":"73","author":"Xu","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0155","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.3390\/cells11233843","article-title":"The role of oxidative stress in atherosclerosis","volume":"11","author":"Batty","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.622736","article-title":"The elusive origin of atherosclerotic plaque calcification","volume":"9","author":"Canet-Soulas","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0165","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/biomedicines8080254","article-title":"Clinical significance of electronegative low-density lipoprotein cholesterol in atherothrombosis","volume":"8","author":"Chu","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0170","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/medicina58020299","article-title":"Atherosclerosis Development and Progression: the Role of Atherogenic small","volume":"58","author":"Vekic","year":"2022","journal-title":"Dense LDL. Medicina"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2015.12.027","article-title":"Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by mendelian randomization analysis in a general Japanese population","volume":"246","author":"Ueshima","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0180","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/0004563216671338","article-title":"Lipoprotein-associated phospholipase A2\u00a0: a new marker to determine cardiovascular risk in hypercholesterolemic dyslipidaemic childre","volume":"54","author":"\u00d6ngen","year":"2017","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0185","doi-asserted-by":"crossref","first-page":"16092","DOI":"10.1038\/s41598-017-16464-5","article-title":"Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China","volume":"7","author":"Huang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110618","article-title":"Risk factors for pre-clinical atherosclerosis in adolescents with type 1 diabetes","volume":"198","author":"Morandi","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0195","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.atherosclerosis.2021.04.007","article-title":"Lysophosphatidylcholine in phospholipase A2-modified LDL triggers secretion of angiopoietin 2","volume":"327","author":"Nguyen","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0200","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2020.200712","article-title":"Clinical Evaluation and Test of a Modified Lp-PLA2 Kit in Diagnosing Atherosclerosis","volume":"67","author":"Yuan","year":"2021","journal-title":"Clin. Lab."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0205","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1021\/acs.jmedchem.5b01534","article-title":"Enhanced sphingomyelinase activity contributes to the apoptotic capacity of electronegative low-density lipoprotein","volume":"59","author":"Ke","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0210","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.5551\/jat.32383","article-title":"Acid sphingomyelinase mediates oxidized-LDL induced apoptosis in macrophage via endoplasmic reticulum stress","volume":"23","author":"Zhao","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0215","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3390\/molecules28052100","article-title":"Effect of sphingomyelinase-treated LDLs on HUVECs","volume":"28","author":"Giuliani","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0220","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/eurheartj\/ehy319","article-title":"Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths","volume":"39","author":"Ruuth","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0225","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bbamem.2019.05.003","article-title":"Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation","volume":"1861","author":"Benitez-Amaro","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Biomembr."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0230","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1021\/acs.jmedchem.2c01643","article-title":"Discovery of novel N -hydroxy-1,2,4-oxadiazole-5-formamides as ASM direct inhibitors for the treatment of atherosclerosis","volume":"66","author":"Yang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carpath.2017.03.009","article-title":"C reactive protein and enzymatically modified LDL cooperatively promote dendritic cell-mediated T cell activation","volume":"29","author":"He","year":"2017","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0240","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/ATVBAHA.116.307306","article-title":"Enzymatically modified low-density lipoprotein promotes foam cell formation in smooth muscle cells via macropinocytosis and enhances receptor-mediated uptake of oxidized low-density lipoprotein","volume":"36","author":"Chellan","year":"2016","journal-title":"ATVB"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0245","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1161\/01.ATV.0000144016.85221.66","article-title":"Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis","volume":"24","author":"Torzewski","year":"2004","journal-title":"ATVB"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0250","first-page":"12","article-title":"Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis","volume":"2021","author":"Alabi","year":"1889","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0255","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.bbadis.2014.07.026","article-title":"Cathepsin G activity Lowers Plasma LDL and Reduces Atherosclerosis","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0260","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2018.04.016","article-title":"Human mast cell neutral proteases generate modified LDL particles with increased proteoglycan binding","volume":"275","author":"Maaninka","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0265","doi-asserted-by":"crossref","first-page":"11488","DOI":"10.3390\/ijms222111488","article-title":"The initial human atherosclerotic lesion and lipoprotein modification\u2014a deep connection","volume":"22","author":"Torzewski","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0270","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3390\/antiox11081565","article-title":"Dicarbonyl-dependent modification of LDL as a key factor of endothelial dysfunction and atherosclerotic vascular wall damage","volume":"11","author":"Lankin","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0275","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/ki.2015.166","article-title":"Protein carbamylation and cardiovascular disease","volume":"88","author":"Verbrugge","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0280","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4239\/wjd.v14.i3.159","article-title":"Carbamylated lipoproteins in diabetes","volume":"14","author":"Denimal","year":"2023","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0285","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/ijms23010574","article-title":"Carbamylated proteins in renal disease: aggravating factors or just biomarkers?","volume":"23","author":"Gorisse","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0290","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/medicina55080493","article-title":"Serum levels of carbamylated LDL and soluble lectin-like oxidized low-density lipoprotein receptor-1 are associated with coronary artery disease in patients with metabolic syndrome","volume":"55","author":"Stankova","year":"2019","journal-title":"Medicina"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0295","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3897\/folmed.61.e39343","article-title":"Serum levels of carbamylated LDL, nitrotyrosine and soluble lectin-like oxidized low-density lipoprotein receptor-1 in poorly controlled type 2 diabetes mellitus","volume":"61","author":"Stankova","year":"2019","journal-title":"FM"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0300","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.jacc.2016.07.755","article-title":"Carbamylated low-density lipoproteins induce a prothrombotic state via LOX-1","volume":"68","author":"Holy","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165576","article-title":"Carbamylated low-density lipoprotein (cLDL)-mediated induction of autophagy and its role in endothelial cell injury","volume":"11","author":"Bose","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0310","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mehy.2019.03.004","article-title":"Could Ornithine supplementation be beneficial to prevent the formation of pro-atherogenic carbamylated low-density lipoprotein (c-LDL) particles?","volume":"126","author":"Simsek","year":"2019","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/708282","article-title":"3-Nitrotyrosine modified proteins in atherosclerosis","volume":"2015","author":"Thomson","year":"2015","journal-title":"Dis. Markers"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2008.07.026","article-title":"LDL Protein Nitration: Implication for LDL Protein Unfolding","volume":"479","author":"Hamilton","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0325","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/352356","article-title":"Plasma nitration of high\u2010density and low\u2010density lipoproteins in chronic kidney disease patients receiving kidney transplants","volume":"2015","author":"Bakillah","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0330","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1042\/CS20150351","article-title":"LDL-lipids from patients with hypercholesterolaemia and Alzheimer\u2019s disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention","volume":"129","author":"Dias","year":"2015","journal-title":"Clin. Sci."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0335","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/antiox11050856","article-title":"Nitrotyrosine, nitrated lipoproteins, and cardiovascular dysfunction in patients with type 2 diabetes: what do we know and what remains to be explained?","volume":"11","author":"Jakubiak","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2019.105037","article-title":"Data of detection and characterization of nitrated conjugated-linoleic acid (NO2-cLA) in LDL","volume":"28","author":"Mastrogiovanni","year":"2020","journal-title":"Data Brief"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.108190","article-title":"Fatty acid nitration in human low-density lipoprotein","volume":"679","author":"Mastrogiovanni","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0350","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0021-9150(93)90066-4","article-title":"Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells","volume":"100","author":"Sobenin","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0355","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/biomedicines10051174","article-title":"Thirty-five-year history of desialylated lipoproteins discovered by vladimir tertov","volume":"10","author":"Glanz","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0360","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/ijms21030817","article-title":"Role of phagocytosis in the pro-inflammatory response in LDL-induced foam cell formation; a transcriptome analysis","volume":"21","author":"Orekhov","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0365","doi-asserted-by":"crossref","first-page":"14689","DOI":"10.1074\/jbc.RA118.004589","article-title":"Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice","volume":"293","author":"White","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0370","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018756","article-title":"Neuraminidases 1 and 3 trigger atherosclerosis by desialylating low\u2010density lipoproteins and increasing their uptake by macrophages","volume":"10","author":"Demina","year":"2021","journal-title":"JAHA"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0375","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.7150\/jca.55526","article-title":"Oxidized-desialylated low-density lipoprotein inhibits the antitumor functions of lymphokine activated killer cells","volume":"12","author":"Aguilar D\u00edaz De Le\u00f3n","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0380","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.2174\/0929867327666200831133912","article-title":"Prospects for the use of sialidase inhibitors in anti-atherosclerotic therapy","volume":"28","author":"Sobenin","year":"2021","journal-title":"CMC"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0385","article-title":"Mouse model of low-density lipoprotein desialylation in vivo","volume":"31","author":"Kashirskikh","year":"2024","journal-title":"CMC"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0390","first-page":"299","article-title":"Increased Lysophosphatidylcholine and Non-Esterified Fatty Acid Content in LDL Induces Chemokine Release in Endothelial Cells","volume":"177","author":"Ben\u00edtez","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0395","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/01.ATV.0000200226.53994.09","article-title":"Elevated concentrations of nonesterified fatty acids increase monocyte expression of CD11b and adhesion to endothelial cells","volume":"26","author":"Zhang","year":"2006","journal-title":"ATVB"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0400","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1194\/jlr.M029629","article-title":"Kinetic analysis of thermal stability of human low density lipoproteins: a model for LDL fusion in atherogenesis","volume":"53","author":"Lu","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0405","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2004.12.033","article-title":"Low density lipoprotein non-esterified fatty acids and lipoprotein lipase in diabetes","volume":"181","author":"Phillips","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0410","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2174\/0929867325666180330093953","article-title":"Electronegative LDL: an active player in atherogenesis or a by- product of atherosclerosis?","volume":"26","author":"Rivas-Urbina","year":"2019","journal-title":"CMC"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0415","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s11883-014-0428-y","article-title":"The underlying chemistry of electronegative LDL\u2019s atherogenicity","volume":"16","author":"Ke","year":"2014","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0420","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2217\/clp.12.26","article-title":"Electronegative LDL: a useful biomarker of cardiovascular risk?","volume":"7","author":"S\u00e1nchez-Quesada","year":"2012","journal-title":"Clinical Lipidology"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0425","first-page":"1015","article-title":"Thermal stability of human plasma electronegative low-density lipoprotein: a paradoxical behavior of low-density lipoprotein aggregation","volume":"1861","author":"Rull","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0430","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1194\/jlr.M009258","article-title":"Proteomic analysis of electronegative low-density lipoprotein","volume":"51","author":"Bancells","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0435","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1194\/jlr.D084301","article-title":"Simultaneous LC\/MS\/MS quantification of eight apolipoproteins in normal and hypercholesterolemic mouse plasma","volume":"60","author":"Wagner","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0440","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tcm.2016.11.002","article-title":"The role of electronegative low-density lipoprotein in cardiovascular diseases and its therapeutic implications","volume":"27","author":"Akyol","year":"2017","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2017.10.016","article-title":"Electronegative L5-LDL induces the production of G-CSF and GM-CSF in human macrophages through LOX-1 involving NF-\u03baB and ERK2 activation","volume":"267","author":"Yang","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0450","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s10753-020-01229-6","article-title":"Electronegative LDL induces M1 polarization of human macrophages through a LOX-1-dependent pathway","volume":"43","author":"Chang","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0455","first-page":"1","article-title":"Electronegative LDL from rabbits fed with atherogenic diet is highly proinflammatory","volume":"2019","author":"Chang","year":"2019","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0460","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s10753-019-01159-y","article-title":"Inflammasome activation in human macrophages induced by a LDL (\u2212) mimetic peptide","volume":"43","author":"Tripodi","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0465","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1016\/j.bbadis.2018.09.022","article-title":"Electronegative LDL induces MMP-9 and TIMP-1 release in monocytes through CD14 activation: inhibitory effect of glycosaminoglycan sulodexide","volume":"1864","author":"Ligi","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0470","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12792","article-title":"Human electronegative LDL induces mitochondrial dysfunction and premature senescence of vascular cells in vivo","volume":"17","author":"Wang","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0475","doi-asserted-by":"crossref","first-page":"9802","DOI":"10.1096\/fj.202000659R","article-title":"Increased APOE glycosylation plays a key role in the atherogenicity of L5 low\u2010density lipoprotein","volume":"34","author":"Ke","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0480","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.RA120000767","article-title":"Adiponectin forms a complex with atherogenic LDL and Inhibits its downstream effects","volume":"62","author":"Kakino","year":"2021","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0485","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/jcm8020177","article-title":"Association between negatively charged low-density lipoprotein L5 and subclinical atherosclerosis in rheumatoid arthritis patients","volume":"8","author":"Chang","year":"2019","journal-title":"JCM"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0490","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.3390\/ijms21165883","article-title":"Association of electronegative LDL with macrophage foam cell formation and CD11c expression in rheumatoid arthritis patients","volume":"21","author":"Chang","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0495","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.atherosclerosis.2017.07.015","article-title":"Increased inflammatory effect of electronegative LDL and decreased protection by HDL in type 2 diabetic patients","volume":"265","author":"Estruch","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0500","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/antiox12020438","article-title":"Electronegative LDL is associated with plaque vulnerability in patients with ischemic stroke and carotid atherosclerosis","volume":"12","author":"Puig","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0505","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2023.05.014","article-title":"Low-Density lipoprotein electronegativity and risk of death after acute coronary syndromes: a case-cohort analysis","volume":"376","author":"Kraler","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2025.111016_b0510","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1038\/s41598-017-04063-3","article-title":"Electronegative low-density lipoprotein increases the risk of ischemic lower-extremity peripheral artery disease in uremia patients on maintenance hemodialysis","volume":"7","author":"Chang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0515","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejpb.2016.07.002","article-title":"A nanoformulation containing a scfv reactive to electronegative LDL inhibits atherosclerosis in LDL receptor knockout mice","volume":"107","author":"Cavalcante","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.clinbiochem.2025.111016_b0520","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.652137","article-title":"scFv-anti-LDL(-)-metal-complex multi-wall functionalized-nanocapsules as a promising tool for the prevention of atherosclerosis progression","volume":"8","author":"Cavalcante","year":"2021","journal-title":"Front. Med."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:42:44Z","timestamp":1783158164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912025001456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":104,"alternative-id":["S0009912025001456"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.111016","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modified LDL variants in atherosclerosis: molecular pathways, diagnostic potential, and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.111016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111016"}}